MetaADEDB 2.0 @ LMMD
Estriol
(PROQIPRRNZUXQM-ZXXIGWHRSA-N)
Structure
SMILES
Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1C[C@H]([C@@H]2O)O)C
Type(s)
Approved; Investigational; Vet_approved
ATC code(s)
G03CA04; G03CC06
Molecular Formula:
C18H24O3
Molecular Weight:
288.381
Log P:
2.5800
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
3
TPSA:
60.69
CAS Number(s):
50-27-1
Synonym(s)
1.
Estriol
2.
(16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol
3.
(16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol
4.
16-alpha-Hydroxy-Estradiol
5.
16alpha,17beta-Estriol
6.
16beta-Hydroxy-Estradiol
7.
Epiestriol
8.
Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol
9.
Ovestin
10.
16 alpha Hydroxy Estradiol
11.
16alpha,17beta Estriol
12.
16beta Hydroxy Estradiol
External Link(s)
MeSHD004964
PubChem Compound5756
BindingDB50410506
ChEBI27974
CHEMBLCHEMBL193482
DrugBankDB04573
DrugCentral3187
IUPHAR/BPS Guide to PHARMACOLOGY2821
KEGGcpd:C05141
dr:D00185
Therapeutic Target DatabaseD0Z1FX
ZINC3815418
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 4SIDER
US FAERS
2Abdominal PainFAERS: 2US FAERS
3PresyncopeFAERS: 2US FAERS
4Toxic Shock SyndromeFAERS: 2US FAERS
5VomitingFAERS: 2US FAERS
6Angina PectorisFAERS: 1US FAERS
7AstheniaFAERS: 1US FAERS
8Bone painFAERS: 1US FAERS
9Burning sensationFAERS: 1US FAERS
10DiscomfortFAERS: 1US FAERS
11DyspepsiaFAERS: 1US FAERS
12Endometrial HyperplasiaFAERS: 116402032CTD
US FAERS
13Endometrial adenocarcinomaFAERS: 1US FAERS
14Gallbladder painFAERS: 1US FAERS
15HypersensitivityFAERS: 1US FAERS
16Lupus-like syndromeFAERS: 1US FAERS
17MalaiseFAERS: 1US FAERS
18Product use in unapproved indicationFAERS: 1US FAERS
19SomnolenceFAERS: 1US FAERS
20Vulvovaginal burning sensationFAERS: 1US FAERS
21Vulvovaginal painFAERS: 1US FAERS
22Acute Coronary SyndromeSIDER
23Application site irritationSIDER
24Atherosclerosis12020746CTD
25Breast discomfortSIDER
26Breast tensionSIDER
27Cerebrovascular accidentSIDER
28ChloasmaSIDER
29DementiaSIDER
30Erythema MultiformeSIDER
31Erythema NodosumSIDER
32Gonadal Dysgenesis2673747CTD
33Hypercholesterolemia2673747CTD
34Hypopituitarism2673747
12970278
CTD
35Ichthyosis, X-Linked9623797
9764665
14641695
CTD
36MalnutritionSIDER
37Myocardial InfarctionSIDER
38PainSIDER
39Pelvic venous thrombosisSIDER
40Postmenopausal spottingSIDER
41PruritusSIDER
42Pulmonary EmbolismSIDER
43Smith-Lemli-Opitz Syndrome17994283CTD
44Vascular purpuraSIDER
45Venous ThromboembolismSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.